We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

276 hedge funds and large institutions have $7.7B invested in CUBIST PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 105 increasing their positions, 107 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $7.35B → $7.7B (+$358M)

3% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 35

0% more funds holding

Funds holding: 276276 (0)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

2% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 107

38% less call options, than puts

Call options by funds: $17.2M | Put options by funds: $27.8M

Holders
276
Holders Change
Holders Change %
0%
% of All Funds
7.97%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.23%
New
36
Increased
105
Reduced
107
Closed
35
Calls
$17.2M
Puts
$27.8M
Net Calls
-$10.6M
Net Calls Change
-$140M
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
1
BNP Paribas Financial Markets
France
$2.03B +$636M +8,525,068 +15,917%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$620M +$92.2M +1,236,276 +17%
PI
3
Putnam Investments
Massachusetts
$498M +$105M +1,402,131 +26%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$402M -$28.4M -380,801 -6%
Vanguard Group
5
Vanguard Group
Pennsylvania
$331M +$14.1M +188,433 +4%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$227M +$10.7M +143,864 +5%
BFA
7
BlackRock Fund Advisors
California
$209M -$1.07M -14,366 -0.5%
Westfield Capital Management
8
Westfield Capital Management
Massachusetts
$197M -$394K -5,284 -0.2%
Federated Hermes
9
Federated Hermes
Pennsylvania
$185M +$16.9M +226,893 +10%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$171M -$11.8M -158,132 -6%
BIT
11
BlackRock Institutional Trust
California
$150M +$5.39M +72,349 +4%
State Street
12
State Street
Massachusetts
$149M +$374K +5,011 +0.2%
MC
13
Maverick Capital
Texas
$127M +$130M +1,739,818 New
AllianceBernstein
14
AllianceBernstein
Tennessee
$118M +$27.9M +373,950 +30%
EAM
15
Eagle Asset Management
Florida
$112M -$53.4M -715,777 -32%
Canada Pension Plan Investment Board
16
Canada Pension Plan Investment Board
Ontario, Canada
$106M -$66M -884,600 -38%
PAI
17
Palo Alto Investors
California
$100M +$2.47M +33,075 +2%
PC
18
PointState Capital
New York
$73.2M +$12M +160,825 +19%
Invesco
19
Invesco
Georgia
$61.3M +$569K +7,635 +0.9%
Deutsche Bank
20
Deutsche Bank
Germany
$58.1M -$24.6M -330,076 -29%
BA
21
BlackRock Advisors
Delaware
$54.7M +$55.1K +739 +0.1%
HM
22
HealthCor Management
New York
$53M -$50.3M -675,000 -48%
CCI
23
Columbus Circle Investors
$50.3M +$30.7M +411,393 +149%
Ameriprise
24
Ameriprise
Minnesota
$50.1M +$17.6M +235,633 +53%
TI
25
Turner Investments
Pennsylvania
$45.2M -$1.62M -21,771 -3%

CBST Hedge Fund Activity: Q1 2014 in Review

276 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2014, worth a combined $7.7B — up 4.9% from $7.35B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CBST positions and 35 closed out — a net gain of 1 holder — while 105 added to existing stakes and 107 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $636M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $66M.

  • 276 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $7.7B of CUBIST PHARMACEUTICALS INC stock for Q1 2014, up 4.9% quarter-over-quarter.
  • 36 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2014 and 35 closed out, a net change of +1 holder.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q1 2014 was BNP Paribas Financial Markets, an estimated $636M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q1 2014 was Canada Pension Plan Investment Board, an estimated $66M sold.

Based on aggregated 13F filings for Q1 2014.